We provide comprehensive genome analysis for newborns to predict long-term genetic diseases. By identifying markers for diabetes, thalassemia, and more, we empower families to take early, life-saving precautions.
By synthesizing a newborn's genomic data shortly after birth, our models calculate risk indices for inheritable conditions, enabling proactive, rather than reactive, healthcare throughout their life.
Non-invasive extraction of DNA samples for comprehensive mapping right after birth.
Scanning for specific genetic markers tied to diabetes, thalassemia, and inherited disorders.
Partnering with clinicians to build lifelong health and dietary plans to mitigate risks.
Discover the power of Novo Aetas biotech infrastructure today. Let's build the future together.